Bender Robert & Associates Merck & Co., Inc. Transaction History

Bender Robert & Associates

  • $471 Million
  • Q3 2024

A detailed history of Bender Robert & Associates transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bender Robert & Associates holds 4,982 shares of MRK stock, worth $506,420. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,982
Previous 5,343 6.76%
Holding current value
$506,420
Previous $661,000 14.52%
% of portfolio
0.12%
Previous 0.15%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$111.15 - $128.97 $553,749 - $642,528
4,982 New
4,982 $565,000
Q1 2024

Apr 22, 2024
SELL
$113.24 - $131.95 $6,794 - $7,916
-60 Reduced 0.89%
6,663 $879,000
Q4 2023

Jan 31, 2024
SELL
$100.18 - $109.02 $24,343 - $26,491
-243 Reduced 3.49%
6,723 $732,000
Q3 2023

Oct 13, 2023
SELL
$102.95 - $114.33 $56,622 - $62,881
-550 Reduced 7.32%
6,966 $717,000
Q2 2023

Jul 13, 2023
SELL
$108.61 - $118.38 $101,658 - $110,803
-936 Reduced 11.07%
7,516 $867,000
Q1 2023

Apr 20, 2023
SELL
$102.94 - $114.86 $14,411 - $16,080
-140 Reduced 1.63%
8,452 $899,000
Q3 2022

Oct 26, 2022
BUY
$84.53 - $94.96 $74,386 - $83,564
880 Added 11.41%
8,592 $740,000
Q1 2022

Apr 14, 2022
BUY
$73.51 - $82.4 $93,357 - $104,648
1,270 Added 19.71%
7,712 $633,000
Q3 2021

Nov 09, 2021
SELL
$71.68 - $78.83 $571,432 - $628,432
-7,972 Reduced 55.31%
6,442 $484,000
Q3 2021

Nov 03, 2021
BUY
$71.68 - $78.83 $575,016 - $632,374
8,022 Added 125.5%
14,414 $24.2 Million
Q2 2021

Jul 16, 2021
BUY
$70.31 - $77.77 $6,327 - $6,999
90 Added 1.43%
6,392 $497,000
Q2 2020

Jul 31, 2020
SELL
$70.42 - $80.13 $11,971 - $13,622
-170 Reduced 2.63%
6,302 $487,000
Q1 2020

Apr 21, 2020
SELL
$63.36 - $87.82 $4,435 - $6,147
-70 Reduced 1.07%
6,472 $498,000
Q4 2019

Jan 31, 2020
SELL
$77.58 - $87.54 $387 - $437
-5 Reduced 0.08%
6,542 $595,000
Q3 2019

Oct 15, 2019
BUY
$76.08 - $82.93 $11,792 - $12,854
155 Added 2.42%
6,547 $551,000
Q2 2019

Jul 30, 2019
SELL
$69.84 - $81.59 $5,587 - $6,527
-80 Reduced 1.24%
6,392 $521,000
Q1 2019

Apr 30, 2019
BUY
$69.58 - $79.36 $7,305 - $8,332
105 Added 1.65%
6,472 $538,000
Q4 2018

Jan 24, 2019
SELL
$65.24 - $75.71 $1,304 - $1,514
-20 Reduced 0.31%
6,367 $487,000
Q2 2018

Jul 27, 2018
BUY
$50.83 - $59.72 $1,524 - $1,791
30 Added 0.47%
6,387 $388,000
Q1 2018

Apr 27, 2018
SELL
$50.96 - $59.23 $7,644 - $8,884
-150 Reduced 2.31%
6,357 $346,000
Q4 2017

Jan 19, 2018
SELL
$51.62 - $61.64 $5,162 - $6,164
-100 Reduced 1.51%
6,507 $366,000
Q3 2017

Oct 23, 2017
BUY
$58.67 - $63.13 $387,632 - $417,099
6,607
6,607 $423,000

Others Institutions Holding MRK

# of Institutions
3,807
Shares Held
1.92B
Call Options Held
13.4M
Put Options Held
10.6M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bender Robert & Associates Portfolio

Follow Bender Robert & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email